Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Renal Failure

  Free Subscription


18.03.2019

1 Am J Nephrol
1 J Am Soc Nephrol
2 J Ren Nutr
1 Lancet
2 Nephrol Dial Transplant
1 Nephron
2 PLoS One
2 Semin Dial


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Nephrol

  1. AKIZAWA T, Macdougall IC, Berns JS, Bernhardt T, et al
    Long-Term Efficacy and Safety of Molidustat for Anemia in Chronic Kidney Disease: DIALOGUE Extension Studies.
    Am J Nephrol. 2019;49:271-280.
    PubMed     Text format     Abstract available


    J Am Soc Nephrol

  2. AUBERT O, Higgins S, Bouatou Y, Yoo D, et al
    Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft Survival.
    J Am Soc Nephrol. 2019 Mar 14. pii: ASN.2018070777. doi: 10.1681/ASN.2018070777.
    PubMed     Text format     Abstract available


    J Ren Nutr

  3. WONG MMY, Thijssen S, Wang Y, Usvyat LA, et al
    Prediction of Mortality and Hospitalization Risk Using Nutritional Indicators and Their Changes Over Time in a Large Prevalent Hemodialysis Cohort.
    J Ren Nutr. 2019 Mar 6. pii: S1051-2276(19)30031.
    PubMed     Text format     Abstract available

  4. SPATOLA L, Finazzi S, Santostasi S, Angelini C, et al
    Geriatric Nutritional Risk Index Is Predictive of Subjective Global Assessment and Dialysis Malnutrition Scores in Elderly Patients on Hemodialysis.
    J Ren Nutr. 2019 Mar 7. pii: S1051-2276(19)30030.
    PubMed     Text format     Abstract available


    Lancet

  5. WESSON DE, Mathur V, Tangri N, Stasiv Y, et al
    Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2019 Mar 8. pii: S0140-6736(18)32562.
    PubMed     Text format     Abstract available


    Nephrol Dial Transplant

  6. SHROFF R, Calder F, Bakkaloglu S, Nagler EV, et al
    Vascular access in children requiring maintenance haemodialysis: a consensus document by the European Society for Paediatric Nephrology Dialysis Working Group.
    Nephrol Dial Transplant. 2019 Mar 11. pii: 5374743. doi: 10.1093.
    PubMed     Text format     Abstract available

  7. BUSHINSKY DA, Chertow GM, Cheng S, Deng H, et al
    One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism.
    Nephrol Dial Transplant. 2019 Mar 11. pii: 5374826. doi: 10.1093.
    PubMed     Text format     Abstract available


    Nephron

  8. TIMMERMANS SAMEG, van Paassen P
    Mother and Child Reunion in "Hypertensive" End-Stage Renal Disease: Will They Complement Each Other?
    Nephron. 2019 Mar 14:1-5. doi: 10.1159/000497779.
    PubMed     Text format     Abstract available


    PLoS One

  9. BLOCK GA, Chertow GM, Sullivan JT, Deng H, et al
    An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism.
    PLoS One. 2019;14:e0213774.
    PubMed     Text format     Abstract available

  10. CHEN SW, Lu YA, Lee CC, Chou AH, et al
    Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study.
    PLoS One. 2019;14:e0212352.
    PubMed     Text format     Abstract available


    Semin Dial

  11. DAUGIRDAS JT
    Intradialytic hypotension and splanchnic shifting: Integrating an overlooked mechanism with the detection of ischemia-related signals during hemodialysis.
    Semin Dial. 2019 Mar 12. doi: 10.1111/sdi.12781.
    PubMed     Text format     Abstract available

  12. WONG LP
    Achieving dialysis safety: The critical role of higher-functioning teams.
    Semin Dial. 2019 Mar 8. doi: 10.1111/sdi.12778.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Renal Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: